| Category: Equity: Sectoral-Pharma and Healthcare |
| Launch Date: 09-06-2025 |
| Asset Class: Equity |
| Benchmark: BSE Healthcare TRI |
| TER: 1.51% As on (29-09-2026) |
| Status: Open Ended Schemes |
| Minimum Investment: 1000.0 |
| Minimum Topup: 1000.0 |
| Total Assets: 487.35 Cr As on 30-09-2026(Source:AMFI) |
| Turn over: 0.69% | Exit Load: Redemption/ switch out of units upto 10% of the units allotted before 1 year from date of allotment- Exit load - NIL. For redemption/switch out of units above 10% of units allotted within 1 year from the date of allotment - 1.00% of applicable NAV. For redemption/switch out of units after 1 year from the date of allotment - Nil. |
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.
| Standard Deviation | - |
| Sharpe Ratio | - |
| Alpha | - |
| Beta | - |
| Yield to Maturity | - |
| Average Maturity | - |
| Scheme Name | Inception Date |
1 Year Return(%) |
2 Year Return(%) |
3 Year Return(%) |
5 Year Return(%) |
10 Year Return(%) |
|---|---|---|---|---|---|---|
| Baroda BNP Paribas Health And Wellness Fund Direct Growth | 09-06-2025 | 5.84 | - | - | - | - |
Small Cap
19.6%
Others
2.94%
Large Cap
31.13%
Mid Cap
46.33%